-
Uncategorized1 month agoSTAT+: OxyContin maker Purdue Pharma set to dissolve after judge approves its criminal sentence
NEWARK, N.J. — OxyContin maker Purdue Pharma is set to be dissolved and replaced by a company focused on the public good by the week’s end,...
-
Uncategorized1 month ago
TxPert: using multiple knowledge graphs for prediction of transcriptomic perturbation effects
Nature Biotechnology, Published online: 01 May 2026; doi:10.1038/s41587-026-03113-4 TxPert predicts unseen single transcriptomic perturbations with accuracy approaching split-half experimental reproducibility.
-
Uncategorized1 month ago
DNA-guided CRISPR–Cas12a effectors for programmable RNA recognition and cleavage
Post Content
-
Uncategorized1 month ago
Brain Glucose Levels Act as a Metabolic Switch for Myelin Formation
Scientists have long known that myelin doesn’t appear everywhere in the brain at once. Some regions myelinate early, others much later, and the timing shapes everything...
-
Uncategorized1 month agoRemembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood
J. Craig Venter, a scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized information machine, died Wednesday at 79. The cause...
-
Uncategorized1 month ago
STAT+: Katherine Szarama named acting director of FDA’s vaccines and biologics center
WASHINGTON — The Food and Drug Administration has named Katherine Szarama as the acting director of the Center for Biologics Evaluation and Research, which regulates vaccines, gene...
-
Uncategorized1 month agoSTAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHA
Now that Casey Means is no longer the Trump administration’s choice for Surgeon General, attention is turning to the third nominee for the position. Nicole Saphier,...
-
Uncategorized1 month agoSTAT+: Hair-raising trial results, and Servier’s M&A wishlist
Why are investors excited about hair loss drugs? Will artificial intelligence make clinical trials run more smoothly? And how does a nonprofit pharma company compete in...
-
Uncategorized1 month agoGenomics Pioneer and Life Sciences Entrepreneur J. Craig Venter Dies at 79
j. Craig Venter, PhD [Heather Kowalski] J. Craig Venter, PhD, the founder, board chair, and CEO of the J. Craig Venter Institute (JCVI) has died in...
-
Uncategorized1 month ago
Merck drops early-stage TROP ADC, keeps deal doors open as Keytruda clock ticks
On the heels of several big buys, Merck still has eyes for M&A—particularly in the oncology, immunology and cardiometabolic spaces—as the quest continues for a candidate...
